No Detail Found!

Comparison of the anaemia and transfusion rates of pregnant women treated with intravenous versus oral iron in the third trimester

Author(s)
Mustafa Cengiz Dura Department of Gynaecology and Obstetrics, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, University of Health Sciences,Istanbul,Turkiye
Ismet Yagiz Dundar Department of Gynaecology and Obstetrics, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, University of Health Sciences,Istanbul,Turkiye
Ozgur Aslan Department of Gynaecology and Obstetrics, Mus State Hospital,Mus,Turkiye
Sukru Yildiz Department of Gynaecology and Obstetrics, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, University of Health Sciences,Istanbul,Turkiye
Gulden Uzer Ekin Department of Family Health, Dogancilar Family Health Centre,Istanbul,Turkiye
Murat Ekin Department of Gynaecology and Obstetrics, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, University of Health Sciences,Istanbul,Turkiye
Abstract
Objective: To evaluate and compare the blood transfusion requirements during delivery in third-trimester pregnant women with iron de ciency anaemia (IDA) who were treated with intravenous (IV) ferric carboxymaltose (FCM) versus those treated with oral iron supplementation. Study Design: Comparative study. Place and Duration of the Study: Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkiye, from January 2017 to December 2022. Methodology: Pregnant women with haemoglobin (Hb) levels <10 g/dL in their third trimester were included. One group (n = 50) received IV FCM, while the other group (n = 96) received oral iron therapy. Key outcome measures included Hb levels at delivery and the need for a postpartum blood transfusion. Inclusion criteria were third-trimester pregnancy with IDA, and exclusion criteria included haematological or chronic systemic diseases and high-risk pregnancies. Results: The mean initial Hb levels in the third trimester of pregnancy in the FCM group and oral iron group were 8.31 ± 0.96 g/dL and 9.29 ± 1.20 g/dL, respectively (p <0.001). The mean Hb levels in the delivery room were 11.09 ± 1.38 and 9.44 ± 1.16 g/dL, respectively (p <0.001). The rates of postpartum erythrocyte transfusion requirement were 6% (n = 3) and 18.75% (n = 18), respectively (p = 0.037). Conclusion: IV FCM administration to pregnant patients with IDA during the third trimester was found to be more e ective than oral iron treatment in reducing blood transfusion rates.
Publication Details
Page(s) 1183-1188
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 34, Issue: 10, Year: 2024

Request the full text from PASTIC

Keywords
Anaemia, Pregnancy, Ferric carboxymaltose, Iron de ciency, Intravenous iron
0

Citations

0

Downloads

102

Views